Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

186 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A Randomized, Double-Blind, Placebo-Controlled, Phase 1 Trial of Radiopaque Islatravir-Eluting Subdermal Implants for Pre-exposure Prophylaxis Against HIV-1 Infection.
Matthews RP, Zang X, Barrett SE, Koynov A, Goodey A, Heimbach T, Weissler VL, Leyssens C, Reynders T, Xu Z, Rottey S, Vargo R, Robertson MN, Stoch SA, Iwamoto M. Matthews RP, et al. Among authors: rottey s. J Acquir Immune Defic Syndr. 2023 Apr 1;92(4):310-316. doi: 10.1097/QAI.0000000000003135. Epub 2022 Nov 29. J Acquir Immune Defic Syndr. 2023. PMID: 36450129 Free PMC article. Clinical Trial.
Assessment of pharmacokinetics, safety, and tolerability following twice-daily administration of molnupiravir for 10 days in healthy participants.
Iwamoto M, Duncan KE, Wickremasingha PK, Zhao T, Liberti MV, Lemoine L, Decaesteker T, Rottey S, Maas BM, Gillespie G, Stoch SA. Iwamoto M, et al. Among authors: rottey s. Clin Transl Sci. 2023 Oct;16(10):1947-1956. doi: 10.1111/cts.13602. Epub 2023 Aug 8. Clin Transl Sci. 2023. PMID: 37526305 Free PMC article. Clinical Trial.
Infrared Spectroscopy: A New Frontier in Hematological Disease Diagnosis.
Delrue C, Speeckaert R, Oyaert M, Kerre T, Rottey S, Coopman R, Huvenne W, De Bruyne S, Speeckaert MM. Delrue C, et al. Among authors: rottey s. Int J Mol Sci. 2023 Nov 30;24(23):17007. doi: 10.3390/ijms242317007. Int J Mol Sci. 2023. PMID: 38069330 Free PMC article. Review.
Avelumab or talazoparib in combination with binimetinib in metastatic pancreatic ductal adenocarcinoma: dose-finding results from phase Ib of the JAVELIN PARP MEKi trial.
Rodon Ahnert J, Tan DS, Garrido-Laguna I, Harb W, Bessudo A, Beck JT, Rottey S, Bahary N, Kotecki N, Zhu Z, Deng S, Kowalski K, Wei C, Pathan N, Laliberte RJ, Messersmith WA. Rodon Ahnert J, et al. Among authors: rottey s. ESMO Open. 2023 Aug;8(4):101584. doi: 10.1016/j.esmoop.2023.101584. Epub 2023 Jun 26. ESMO Open. 2023. PMID: 37379764 Free PMC article. Clinical Trial.
Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR): an international, single-arm, phase 2 study.
Pant S, Schuler M, Iyer G, Witt O, Doi T, Qin S, Tabernero J, Reardon DA, Massard C, Minchom A, Lugowska I, Carranza O, Arnold D, Gutierrez M, Winter H, Stuyckens K, Crow L, Najmi S, Hammond C, Thomas S, Santiago-Walker A, Triantos S, Sweiti H, Loriot Y; RAGNAR Investigators. Pant S, et al. Lancet Oncol. 2023 Aug;24(8):925-935. doi: 10.1016/S1470-2045(23)00275-9. Lancet Oncol. 2023. PMID: 37541273 Free PMC article. Clinical Trial.
Autogene cevumeran with or without atezolizumab in advanced solid tumors: a phase 1 trial.
Lopez J, Powles T, Braiteh F, Siu LL, LoRusso P, Friedman CF, Balmanoukian AS, Gordon M, Yachnin J, Rottey S, Karydis I, Fisher GA, Schmidt M, Schuler M, Sullivan RJ, Burris HA, Galvao V, Henick BS, Dirix L, Jaeger D, Ott PA, Wong KM, Jerusalem G, Schiza A, Fong L, Steeghs N, Leidner RS, Rittmeyer A, Laurie SA, Gort E, Aljumaily R, Melero I, Sabado RL, Rhee I, Mancuso MR, Muller L, Fine GD, Yadav M, Kim L, Leveque VJP, Robert A, Darwish M, Qi T, Zhu J, Zhang J, Twomey P, Rao GK, Low DW, Petry C, Lo AA, Schartner JM, Delamarre L, Mellman I, Löwer M, Müller F, Derhovanessian E, Cortini A, Manning L, Maurus D, Brachtendorf S, Lörks V, Omokoko T, Godehardt E, Becker D, Hawner C, Wallrapp C, Albrecht C, Kröner C, Tadmor AD, Diekmann J, Vormehr M, Jork A, Paruzynski A, Lang M, Blake J, Hennig O, Kuhn AN, Sahin U, Türeci Ö, Camidge DR. Lopez J, et al. Among authors: rottey s. Nat Med. 2025 Jan 6. doi: 10.1038/s41591-024-03334-7. Online ahead of print. Nat Med. 2025. PMID: 39762422
A comprehensive view of N-glycosylation as clinical biomarker in prostate cancer.
Eggermont L, Lumen N, Van Praet C, Delanghe J, Rottey S, Vermassen T. Eggermont L, et al. Among authors: rottey s. Biochim Biophys Acta Rev Cancer. 2024 Dec 11;1880(1):189239. doi: 10.1016/j.bbcan.2024.189239. Online ahead of print. Biochim Biophys Acta Rev Cancer. 2024. PMID: 39672278 Review.
186 results